Compare · PRKS vs SLNO
PRKS vs SLNO
Side-by-side comparison of United Parks & Resorts Inc. (PRKS) and Soleno Therapeutics Inc. (SLNO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PRKS and SLNO operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- SLNO is the larger of the two at $2.76B, about 1.4x PRKS ($1.95B).
- Over the past year, PRKS is down 0.5% and SLNO is down 31.8% - PRKS leads by 31.3 points.
- SLNO has been more active in the news (39 items in the past 4 weeks vs 2 for PRKS).
- SLNO has more recent analyst coverage (12 ratings vs 6 for PRKS).
- Company
- United Parks & Resorts Inc.
- Soleno Therapeutics Inc.
- Price
- $42.67+4.67%
- $53.02+0.08%
- Market cap
- $1.95B
- $2.76B
- 1M return
- +14.95%
- +0.76%
- 1Y return
- -0.48%
- -31.78%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 2013
- 2014
- News (4w)
- 2
- 39
- Recent ratings
- 6
- 12
Soleno Therapeutics Inc.
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics has collaboration with Vanderbilt University to discover and develop next generation K(ATP) channel activators for the treatment of rare diseases. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
Latest PRKS
- BUSCH GARDENS TURNS UP THE HEAT THIS SUMMER WITH ALL-NEW ENTERTAINMENT, DRONE SHOWS, THRILLING EXPERIENCES, AND FREE BEER*
- SEAWORLD REACHES MILESTONE OF 43,000 ANIMAL RESCUES, UNDERSCORING THE ONGOING NEED TO HELP ANIMALS IN NEED
- United Parks & Resorts Inc. downgraded by Stifel with a new price target
- SEC Form 10-Q filed by United Parks & Resorts Inc.
- United Parks & Resorts Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- United Parks & Resorts Inc. Reports First Quarter 2026 Results
- United Parks & Resorts Inc. upgraded by Mizuho with a new price target
- SeaWorld Parks Unveil Coast-to-Coast Summer Spectacular Lineup in Orlando, San Diego and San Antonio
- Chief Legal Officer Kelly Thomas Brian was granted 47,169 shares (SEC Form 4)
- SEC Form 3 filed by new insider Kelly Thomas Brian
Latest SLNO
- SEC Form 15-12G filed by Soleno Therapeutics Inc.
- SEC Form EFFECT filed by Soleno Therapeutics Inc.
- SEC Form POS AM filed by Soleno Therapeutics Inc.
- SEC Form AW filed by Soleno Therapeutics Inc.
- Officer Yen Kristen returned 37,639 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Volck Birgitte returned 17,536 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Sinclair Andrew returned 10,491 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Pauls Matthew returned 10,491 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Chief Business Officer Norrett Kevin returned 17,786 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Chief Commercial Officer Manning Meredith returned 64,507 shares to the company, closing all direct ownership in the company (SEC Form 4)